4 employees
HBOX Therapies develops therapies based on the principle of minimally invasive targeted hyperoxygenation.
2021
$2.4M
from 1 investors over 1 rounds
HBOX Therapies raised $2.4M on February 22, 2023
Investors: High-Tech Gründerfonds